Provided are a prophylactic and/or therapeutic agent for diseases involving IDO expression and a pharmaceutical composition for treating IDO-positive tumors. The prophylactic and/or therapeutic agent for diseases involving IDO expression and the pharmaceutical composition for treating IDO-positive tumors comprise, as an active ingredient, a compound inhibiting HSP90.